Author: Helitra.com

Cigna to offer biosimilar to J&J’s arthritis drug Stelara at $0 out-of-pocket Source: Seekingalpha

Eli Lilly bets $409M for AI-focused drug discovery Source: Seekingalpha

Lisata jumps on FDA orphan drug status for liver cancer drug Source: Seekingalpha

Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: Seekingalpha

Vor Bio stock rallies post-market on trem-cel study data Source: Seekingalpha

aTyr started at buy by Jefferies, citing efzofitimod potential Source: Seekingalpha

Kits Eyecare announces $10.15M secondary offering Source: Seekingalpha

Fanhua and Shanghai Biotecan Pharmaceuticals enters into cooperation agreement Source: Seekingalpha

Travere gains on full FDA approval for kidney drug Filspari Source: Seekingalpha

GSK’s Nucala succeeds in late-stage study for lung dysfunction, COPD Source: Seekingalpha